[144] Aldeyra Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Aldeyra Therapeutics (ALDX) Form 144 reports a proposed sale of 22,074 shares of common stock through Morgan Stanley Smith Barney on Nasdaq, with an aggregate market value of $116,109.24 and an approximate sale date of 08/12/2025. The filing states the shares were acquired as a Restricted Stock Unit grant on 07/15/2022 (46,401 units acquired) and that the consideration for the original acquisition was services rendered. The filer reports nothing to report for securities sold in the past three months.

The notice includes the seller's representation that they are not aware of any undisclosed material adverse information regarding the issuer.

Insights

Financial Analyst

TL;DR: Insider plans to sell 22,074 ALDX shares (aggregate $116,109); sale stems from a 2022 RSU grant and no recent sales are reported — neutral disclosure.

The Form 144 specifies the broker as Morgan Stanley Smith Barney LLC and lists the transaction as common stock to be sold on Nasdaq with an approximate sale date of 08/12/2025. Acquisition details show the securities originated from a Restricted Stock Unit grant dated 07/15/2022 (46,401 units acquired) and payment for the grant was for services rendered. The filing also states Nothing to Report for sales in the past three months, indicating no recent disposals disclosed in this notice.

Corporate Governance Expert

TL;DR: This Form 144 documents a routine proposed disposition of vested RSUs; the filing contains required representations and no prior 3-month sales.

The notice includes the seller's standard certification about lacking undisclosed material adverse information and shows the sale will be executed through Morgan Stanley Smith Barney. The securities to be sold were acquired from the issuer as an RSU grant on 07/15/2022 (46,401 units), with 22,074 shares listed for proposed sale. The filing records nothing to report for sales during the prior three months, consistent with a routine insider disposition disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza, 8th Floor New York NY 10004	22074	116109.24	59895588	08/12/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/15/2022	Restricted Stock Unit Grant	Issuer			46401	07/15/2022	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ALDX Form 144 report?

The Form 144 reports a proposed sale of 22,074 Aldeyra Therapeutics (ALDX) common shares valued at $116,109.24, to be sold on Nasdaq via Morgan Stanley Smith Barney LLC with an approximate sale date of 08/12/2025.

How were the securities being sold acquired?

The securities were acquired as a Restricted Stock Unit grant from the issuer on 07/15/2022, totaling 46,401 units; the grant consideration is listed as services rendered.

Did the filer report any securities sold in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker and exchange are involved in the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC (1 New York Plaza, 8th Floor, New York, NY) and the sale is listed on Nasdaq.

How many shares outstanding does the filing list?

The filing lists 59,895,588 shares outstanding for the issuer.